GRAFT VS HOST DISEASE
Clinical trials for GRAFT VS HOST DISEASE explained in plain language.
Never miss a new study
Get alerted when new GRAFT VS HOST DISEASE trials appear
Sign up with your email to follow new studies for GRAFT VS HOST DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to shield young transplant patients from dangerous immune attack
Disease control OngoingThis study tests whether adding the drug vorinostat to standard care can prevent graft-versus-host disease (GVHD) in children, adolescents, and young adults receiving a bone marrow or blood stem cell transplant for blood cancers or disorders. About 43 participants will receive vo…
Matched conditions: GRAFT VS HOST DISEASE
Phase: PHASE1, PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated May 17, 2026 11:37 UTC
-
New device could make bone marrow transplants safer for blood cancer patients
Disease control TerminatedThis study tests a special device that removes certain immune cells from donated blood stem cells before transplant. The goal is to lower the risk of graft-versus-host disease, a serious complication where the donor cells attack the patient's body. About 50 adults with myelodyspl…
Matched conditions: GRAFT VS HOST DISEASE
Phase: PHASE2 • Sponsor: Guenther Koehne • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
Lifeline for patients: extended ibrutinib access trial launches
Disease control OngoingThis study offers ongoing access to the drug ibrutinib for people with certain blood cancers or graft-versus-host disease who completed earlier ibrutinib trials and are still seeing benefits. Participants continue their treatment while researchers collect long-term safety informa…
Matched conditions: GRAFT VS HOST DISEASE
Phase: PHASE4 • Sponsor: Pharmacyclics Switzerland GmbH • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
New drug cocktail aims to tame deadly transplant complication
Disease control OngoingThis study tests whether a reduced-dose combination of three drugs (cyclophosphamide, abatacept, and tacrolimus) can prevent graft-versus-host disease (GVHD) in 27 adults with blood cancers receiving a stem cell transplant from a half-matched donor. GVHD occurs when donor immune …
Matched conditions: GRAFT VS HOST DISEASE
Phase: PHASE2 • Sponsor: NYU Langone Health • Aim: Disease control
Last updated May 06, 2026 16:03 UTC
-
New Light-Based scanner aims to spot inflammation without needles
Diagnosis TerminatedThis study is testing a new, non-invasive imaging device called MSOT that uses light and sound to detect inflammation in the skin or gut. It includes 100 adults with graft-versus-host disease, Crohn's disease, or colitis. The main goal is to see if the device is safe and can help…
Matched conditions: GRAFT VS HOST DISEASE
Phase: NA • Sponsor: University of Oklahoma • Aim: Diagnosis
Last updated May 17, 2026 11:34 UTC
-
Light therapy shows promise for tight skin diseases
Symptom relief OngoingThis study looks at whether 30 sessions of UVA-1 light therapy can improve how people with scleroderma, morphea, or skin-related graft-versus-host disease feel and function in daily life. About 30 adults will receive the treatment and report their symptoms using questionnaires. T…
Matched conditions: GRAFT VS HOST DISEASE
Phase: NA • Sponsor: University of Utah • Aim: Symptom relief
Last updated May 17, 2026 11:38 UTC
-
New group program aims to boost quality of life for stem cell transplant survivors
Symptom relief OngoingThis study looks at whether a group-based program called Horizons can help adults with chronic graft-versus-host disease (cGVHD) improve their quality of life and coping skills. About 20 people who had a stem cell transplant and now have moderate to severe cGVHD will take part. T…
Matched conditions: GRAFT VS HOST DISEASE
Phase: NA • Sponsor: University of Miami • Aim: Symptom relief
Last updated May 13, 2026 16:03 UTC
-
New program aims to ease daily struggles for GVHD patients
Symptom relief OngoingThis study tests a special program called Horizons for adults who have had a stem cell transplant and developed chronic graft-versus-host disease (GVHD). The program includes group sessions to help patients cope with symptoms, improve quality of life, and take their medications a…
Matched conditions: GRAFT VS HOST DISEASE
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated May 08, 2026 12:02 UTC
-
Massive study aims to decode immune secrets of gut diseases and transplant rejection
Knowledge-focused ENROLLING_BY_INVITATIONThis study is collecting blood and tissue samples from 1,000 people with inflammatory bowel disease (IBD), graft-versus-host disease (GVHD), or functional gut disorders, as well as those receiving cell therapies like CAR-T. Researchers will analyze the immune system in detail to …
Matched conditions: GRAFT VS HOST DISEASE
Sponsor: Boston Children's Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 11:33 UTC
-
New tools to gauge GVHD treatment response
Knowledge-focused OngoingThis study involves 383 people who have chronic Graft-versus-Host Disease (GVHD) after a stem cell transplant. Researchers are developing and testing new measurement tools to more accurately determine if a patient is responding to treatment. The goal is to better predict which th…
Matched conditions: GRAFT VS HOST DISEASE
Sponsor: Fred Hutchinson Cancer Center • Aim: Knowledge-focused
Last updated May 04, 2026 16:21 UTC